Drupal.behaviors.print = function(context) {window.print();window.close();}>
Janssen Biotech, Pharmacyclics Explore Abbott FISH Technology as CDx for CLL
February 21, 2013
Janssen Biotech, Pharmacyclics Explore Abbott FISH Technology as CDx for CLL
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Abbott to Develop Companion Dx for Epizyme Cancer Drug Candidate
April 18, 2013 / GenomeWeb Daily News
Abbott, GSK Expand Partnership for Additional Companion Dx
November 28, 2011 / GenomeWeb Daily News
Abbott Gets Sub-license to Develop Companion Dx for Pfizer Drug
July 6, 2011 / GenomeWeb Daily News
Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News
Merck, Luminex Partner to Advance Companion Test for Alzheimer's Drug
March 13, 2013 / GenomeWeb Daily News